SEPTIN9 and colorectal carcinoma: The Food and Drug Administration (FDA) presently approves the measurement of plasma methylated septin 9 (mSEPT9), the sole blood-based test for CRC detection, for CRC screening in people who are unwilling or unable to perform the higher efficacy screening tests [31].